Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meri K Tulic

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Antioxidants (Basel, Switzerland)|April 30, 2021
Differential and Overlapping Effects of Melatonin and Its Metabolites on Keratinocyte Function: Bioinformatics and Metabolic AnalysesJoanna Stefan, Tae-Kang Kim, Fiona Schedel, et al.
International Journal of Molecular Sciences|April 17, 2025
Correction: Möller et al. Melanogenesis Is Directly Affected by Metabolites of Melatonin in Human Melanoma Cells. <i>Int. J. Mol. Sci.</i> 2023, <i>24,</i> 14947Jack K S Möller, Kinga Linowiecka, Maciej Gagat, et al.
International Journal of Molecular Sciences|October 14, 2023
Melanogenesis Is Directly Affected by Metabolites of Melatonin in Human Melanoma CellsJack K S Möller, Kinga Linowiecka, Maciej Gagat, et al.
Clinical and Translational Medicine|August 8, 2024
Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategiesAna C B Sant'Anna-Silva, Thomas Botton, Andrea Rossi, et al.
Molecular Cancer|January 8, 2021
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicityYann Cheli, Meri K Tulic, Najla El Hachem, et al.
Molecular Cancer|January 28, 2021
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicityYann Cheli, Meri K Tulic, Najla El Hachem, et al.
The Journal of Allergy and Clinical Immunology|June 9, 2009
Neonatal innate cytokine responses to BCG controlling T-cell development vary between populationsAnita H J van den Biggelaar, Susan L Prescott, Marjut Roponen, et al.
The Journal of Investigative Dermatology|July 26, 2021
CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3Henri Montaudié, Laura Sormani, Bérengère Dadone-Montaudié, et al.
Cell Death & Disease|May 11, 2018
E2F1 inhibition mediates cell death of metastatic melanomaFlorian Rouaud, Nedra Hamouda-Tekaya, Michaël Cerezo, et al.
The Journal of Investigative Dermatology|December 13, 2021
CLEC12B Is a Melanocytic Gene Regulating the Color of the SkinLaura Sormani, Henri Montaudie, Lauriane Blot, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Antioxidants (Basel, Switzerland)|April 30, 2021
Differential and Overlapping Effects of Melatonin and Its Metabolites on Keratinocyte Function: Bioinformatics and Metabolic AnalysesJoanna Stefan, Tae-Kang Kim, Fiona Schedel, et al.
International Journal of Molecular Sciences|April 17, 2025
Correction: Möller et al. Melanogenesis Is Directly Affected by Metabolites of Melatonin in Human Melanoma Cells. <i>Int. J. Mol. Sci.</i> 2023, <i>24,</i> 14947Jack K S Möller, Kinga Linowiecka, Maciej Gagat, et al.
International Journal of Molecular Sciences|October 14, 2023
Melanogenesis Is Directly Affected by Metabolites of Melatonin in Human Melanoma CellsJack K S Möller, Kinga Linowiecka, Maciej Gagat, et al.
Clinical and Translational Medicine|August 8, 2024
Vitiligo auto-immune response upon oxidative stress-related mitochondrial DNA release opens up new therapeutic strategiesAna C B Sant'Anna-Silva, Thomas Botton, Andrea Rossi, et al.
Molecular Cancer|January 8, 2021
ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicityYann Cheli, Meri K Tulic, Najla El Hachem, et al.
Molecular Cancer|January 28, 2021
Correction to: ITGBL1 is a new immunomodulator that favors development of melanoma tumors by inhibiting natural killer cells cytotoxicityYann Cheli, Meri K Tulic, Najla El Hachem, et al.
The Journal of Allergy and Clinical Immunology|June 9, 2009
Neonatal innate cytokine responses to BCG controlling T-cell development vary between populationsAnita H J van den Biggelaar, Susan L Prescott, Marjut Roponen, et al.
The Journal of Investigative Dermatology|July 26, 2021
CLEC12B Decreases Melanoma Proliferation by Repressing Signal Transducer and Activator of Transcription 3Henri Montaudié, Laura Sormani, Bérengère Dadone-Montaudié, et al.
Cell Death & Disease|May 11, 2018
E2F1 inhibition mediates cell death of metastatic melanomaFlorian Rouaud, Nedra Hamouda-Tekaya, Michaël Cerezo, et al.
The Journal of Investigative Dermatology|December 13, 2021
CLEC12B Is a Melanocytic Gene Regulating the Color of the SkinLaura Sormani, Henri Montaudie, Lauriane Blot, et al.
Pageof 7